Biofilm-forming capacity of blood–borne Candida albicans strains and effects of antifungal agents
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Revista Argentina de Microbiologia
- Vol. 50 (1) , 62-69
Abstract
No abstract availableKeywords
Funding Information
- Baskent University Research Fund
This publication has 37 references indexed in Scilit:
- Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011Journal of Clinical Microbiology, 2012
- Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilmsJournal of Antimicrobial Chemotherapy, 2011
- Antibiotic-Induced Biofilm FormationThe International Journal of Artificial Organs, 2011
- In Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans IsolatesAntimicrobial Agents and Chemotherapy, 2009
- In Vitro Activity of Anidulafungin against Candida albicans BiofilmsAntimicrobial Agents and Chemotherapy, 2008
- Stimulation of Chitin Synthesis Rescues Candida albicans from EchinocandinsPLOS Pathogens, 2008
- Differential Activities of Newer Antifungal Agents against Candida albicans and Candida parapsilosis BiofilmsAntimicrobial Agents and Chemotherapy, 2008
- Species-Specific Differences in the Susceptibilities of Biofilms Formed by Candida Bloodstream Isolates to Echinocandin AntifungalsAntimicrobial Agents and Chemotherapy, 2007
- Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazoleJournal of Antimicrobial Chemotherapy, 2007
- Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis ofCandida albicansFEMS Microbiology Letters, 2000